Palo Alto Investors

Latest statistics and disclosures from Palo Alto Investors's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Palo Alto Investors

Palo Alto Investors holds 34 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Insmed Com Par $.01 (INSM) 15.4 $171M -6% 5.5M 30.99
 View chart
Amicus Therapeutics (FOLD) 13.3 $147M 10M 14.19
 View chart
BioMarin Pharmaceutical (BMRN) 13.0 $145M -18% 1.5M 96.42
 View chart
Biogen Idec (BIIB) 8.9 $98M 380k 258.77
 View chart
United Therapeutics Corporation (UTHR) 7.8 $87M -31% 396k 219.89
 View chart
ACADIA Pharmaceuticals (ACAD) 6.8 $75M 2.4M 31.31
 View chart
Prothena Corp SHS (PRTA) 5.4 $60M 1.7M 36.34
 View chart
Revance Therapeutics (RVNC) 4.1 $46M 5.2M 8.79
 View chart
Staar Surgical Com Par $0.01 (STAA) 3.9 $43M 1.4M 31.21
 View chart
Alnylam Pharmaceuticals (ALNY) 2.7 $30M NEW 154k 191.41
 View chart
eHealth (EHTH) 2.2 $24M 2.7M 8.72
 View chart
Sage Therapeutics (SAGE) 1.9 $22M 992k 21.67
 View chart
Sarepta Therapeutics (SRPT) 1.7 $19M +113% 201k 96.43
 View chart
Iovance Biotherapeutics (IOVA) 1.5 $17M NEW 2.1M 8.13
 View chart
Alkermes SHS (ALKS) 1.5 $17M 603k 27.74
 View chart
Nevro (NVRO) 1.5 $16M +93% 750k 21.52
 View chart
Align Technology (ALGN) 1.4 $15M 56k 274.00
 View chart
Anaptysbio Inc Common (ANAB) 1.3 $15M +59% 687k 21.42
 View chart
Syndax Pharmaceuticals (SNDX) 0.9 $10M 473k 21.61
 View chart
Cytokinetics Com New (CYTK) 0.8 $9.3M 112k 83.49
 View chart
Novocure Ord Shs (NVCR) 0.8 $8.4M -14% 562k 14.93
 View chart
Verve Therapeutics (VERV) 0.7 $8.0M NEW 576k 13.94
 View chart
Gossamer Bio (GOSS) 0.6 $6.5M -8% 6.0M 1.10
 View chart
Bluebird Bio (BLUE) 0.4 $4.6M NEW 3.3M 1.38
 View chart
Karyopharm Therapeutics (KPTI) 0.4 $4.4M -10% 5.1M 0.86
 View chart
Relmada Therapeutics (RLMD) 0.3 $3.0M 732k 4.14
 View chart
Mirum Pharmaceuticals (MIRM) 0.2 $1.9M 65k 29.52
 View chart
Vanda Pharmaceuticals (VNDA) 0.1 $1.2M 279k 4.22
 View chart
Vyne Therapeutics (VYNE) 0.1 $1.0M NEW 445k 2.33
 View chart
Travere Therapeutics (TVTX) 0.1 $995k -33% 111k 8.99
 View chart
Taysha Gene Therapies Com Shs (TSHA) 0.1 $938k NEW 530k 1.77
 View chart
Sight Sciences (SGHT) 0.1 $897k NEW 174k 5.16
 View chart
Aldeyra Therapeutics (ALDX) 0.1 $791k +40% 226k 3.51
 View chart
Urogen Pharma (URGN) 0.0 $368k 25k 15.00
 View chart

Past Filings by Palo Alto Investors

SEC 13F filings are viewable for Palo Alto Investors going back to 2010

View all past filings